Synaptic and metabolic gene expression alterations in neurons that are recipients of proteopathic tau seeds.


Journal

Acta neuropathologica communications
ISSN: 2051-5960
Titre abrégé: Acta Neuropathol Commun
Pays: England
ID NLM: 101610673

Informations de publication

Date de publication:
19 10 2020
Historique:
received: 13 08 2020
accepted: 02 10 2020
entrez: 20 10 2020
pubmed: 21 10 2020
medline: 11 11 2021
Statut: epublish

Résumé

Recent studies suggest that misfolded tau molecules can be released, and taken up by adjacent neurons, propagating proteopathic seeds across neural systems. Yet critical to understanding whether tau propagation is relevant in pathophysiology of disease would be to learn if it alters neuronal properties. We utilized high resolution multi-color in situ hybridization technology, RNAScope, in a well-established tau transgenic animal, and found that a subset of neurons in the cortex do not appear to express the transgene, but do develop phospho-tau positive inclusions, consistent with having received tau seeds. Recipient neurons show decreases in their expression of synaptophysin, CAMKIIα, and mouse tau in both young and old animals. These results contrast with neurons that develop tau aggregates and also overexpress the transgene, which have few changes in expression of metabolic and synaptic markers. Taken together, these results strongly suggest that tau propagation impacts neuronal functional integrity.

Identifiants

pubmed: 33076986
doi: 10.1186/s40478-020-01049-7
pii: 10.1186/s40478-020-01049-7
pmc: PMC7574323
doi:

Substances chimiques

MAPT protein, human 0
Mapt protein, mouse 0
RNA, Messenger 0
Synaptophysin 0
tau Proteins 0
Calcium-Calmodulin-Dependent Protein Kinase Type 2 EC 2.7.11.17
Camk2a protein, mouse EC 2.7.11.17

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

168

Subventions

Organisme : NIA NIH HHS
ID : P30 AG062421
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG059789
Pays : United States
Organisme : NIA NIH HHS
ID : RF1AG059789-01
Pays : United States

Références

J Exp Med. 2016 Nov 14;213(12):2635-2654
pubmed: 27810929
J Neuropathol Exp Neurol. 1999 Mar;58(3):275-87
pubmed: 10197819
Acta Neuropathol. 2015 Feb;129(2):221-37
pubmed: 25534024
PLoS One. 2012;7(2):e31302
pubmed: 22312444
Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9535-40
pubmed: 23690619
Nat Med. 2020 Aug;26(8):1256-1263
pubmed: 32572268
Ann Neurol. 1986 Oct;20(4):472-81
pubmed: 3789663
Acta Neuropathol Commun. 2014 Jan 30;2:14
pubmed: 24479894
J Neurosci. 2005 Nov 16;25(46):10637-47
pubmed: 16291936
Acta Neuropathol. 2020 Jan;139(1):3-25
pubmed: 31686182
Nat Commun. 2019 Jun 6;10(1):2479
pubmed: 31171783
Nucleic Acids Res. 1997 Sep 1;25(17):3389-402
pubmed: 9254694
Neurobiol Aging. 2006 Oct;27(10):1359-71
pubmed: 16242812
J Neurosci. 2019 Nov 27;39(48):9623-9632
pubmed: 31658988
Science. 2005 Jul 15;309(5733):476-81
pubmed: 16020737
FEBS J. 2005 Oct;272(20):5101-9
pubmed: 16218944
Acta Neuropathol. 1991;82(4):239-59
pubmed: 1759558
Nat Rev Neurosci. 2015 Feb;16(2):109-20
pubmed: 25588378
Cell Rep. 2020 Feb 11;30(6):2040-2054.e5
pubmed: 32049030
Neuron. 2014 Jun 18;82(6):1271-88
pubmed: 24857020
Cell Rep. 2019 Jul 23;28(4):1103-1116.e4
pubmed: 31340147
Nat Commun. 2015 Oct 13;6:8490
pubmed: 26458742
J Cell Biol. 2002 Mar 18;156(6):1051-63
pubmed: 11901170
Acta Neuropathol Commun. 2017 Dec 19;5(1):99
pubmed: 29258615
Front Neurosci. 2018 Apr 24;12:267
pubmed: 29740275
J Biol Chem. 2015 Jan 9;290(2):1049-65
pubmed: 25406315
Annu Rev Neurosci. 2015 Jul 8;38:87-103
pubmed: 25840008
Nat Neurosci. 2019 Jan;22(1):57-64
pubmed: 30559471
J Neurosci. 2017 Nov 22;37(47):11406-11423
pubmed: 29054878
Sci Adv. 2019 Jun 26;5(6):eaaw6404
pubmed: 31249873
Front Cell Neurosci. 2015 Aug 25;9:318
pubmed: 26379494
Neuron. 2012 Feb 23;73(4):685-97
pubmed: 22365544

Auteurs

Marta Perez-Rando (M)

Alzheimer Research Unit, Department of Neurology, Massachusetts General Hospital, Building 114, Room 2009, Charlestown, MA, 02129, USA.
Harvard Medical School, Boston, MA, USA.

Simon Dujardin (S)

Alzheimer Research Unit, Department of Neurology, Massachusetts General Hospital, Building 114, Room 2009, Charlestown, MA, 02129, USA.
Harvard Medical School, Boston, MA, USA.

Rachel E Bennett (RE)

Alzheimer Research Unit, Department of Neurology, Massachusetts General Hospital, Building 114, Room 2009, Charlestown, MA, 02129, USA.
Harvard Medical School, Boston, MA, USA.

Caitlin Commins (C)

Alzheimer Research Unit, Department of Neurology, Massachusetts General Hospital, Building 114, Room 2009, Charlestown, MA, 02129, USA.

Tara Nibhanupudy (T)

Alzheimer Research Unit, Department of Neurology, Massachusetts General Hospital, Building 114, Room 2009, Charlestown, MA, 02129, USA.

Bradley T Hyman (BT)

Alzheimer Research Unit, Department of Neurology, Massachusetts General Hospital, Building 114, Room 2009, Charlestown, MA, 02129, USA. bhyman@mgh.harvard.edu.
Harvard Medical School, Boston, MA, USA. bhyman@mgh.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH